| MeSH term | MeSH ID | Detail |
|---|---|---|
| Alcoholic Intoxication | D000435 | 15 associated lipids |
| Angina, Unstable | D000789 | 14 associated lipids |
| Aortic Aneurysm | D001014 | 8 associated lipids |
| Ascites | D001201 | 25 associated lipids |
| Bartter Syndrome | D001477 | 5 associated lipids |
| Body Weight | D001835 | 333 associated lipids |
| Cardiovascular Diseases | D002318 | 24 associated lipids |
| Carotid Artery Thrombosis | D002341 | 7 associated lipids |
| Cerebral Hemorrhage | D002543 | 13 associated lipids |
| Cerebrovascular Disorders | D002561 | 25 associated lipids |
2,3-dinor, 6-keto-PGF1alpha
2,3-dinor, 6-keto-pgf1alpha is a lipid of Fatty Acyls (FA) class.
Cross Reference
There are no associated biomedical information in the current reference collection.
Current reference collection contains 782 references associated with 2,3-dinor, 6-keto-PGF1alpha in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.
Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.
Here are additional resources we collected from PubChem and MeSH for 2,3-dinor, 6-keto-PGF1alpha
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with 2,3-dinor, 6-keto-PGF1alpha
NCBI Entrez Crosslinks
All references with 2,3-dinor, 6-keto-PGF1alpha
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Daniel VC et al. | Simplified assay for the quantification of 2,3-dinor-6-keto-prostaglandin F1 alpha by gas chromatography-mass spectrometry. | 1994 | J. Chromatogr. B, Biomed. Appl. | pmid:8205238 |
| Adatia I et al. | Thromboxane A2 and prostacyclin biosynthesis in children and adolescents with pulmonary vascular disease. | 1993 | Circulation | pmid:8222105 |
| Bordet JC et al. | Systemic but not renal production of prostacyclin is highly reduced in cyclosporin-treated heart transplant recipients. | 1993 | Am. J. Cardiol. | pmid:8352201 |
| Adatia I et al. | Abnormalities in the biosynthesis of thromboxane A2 and prostacyclin in children with cyanotic congenital heart disease. | 1993 | Br Heart J | pmid:8435245 |
| Foulon I et al. | Increased in vivo production of thromboxane in patients with sickle cell disease is accompanied by an impairment of platelet functions to the thromboxane A2 agonist U46619. | 1993 | Arterioscler. Thromb. | pmid:8443146 |
| Benowitz NL et al. | Nicotine effects on eicosanoid formation and hemostatic function: comparison of transdermal nicotine and cigarette smoking. | 1993 | J. Am. Coll. Cardiol. | pmid:7691912 |
| Wennmalm A et al. | Maintained hyperexcretion of thromboxane A2 metabolite in healthy young cigarette smokers: results from a prospective study in randomly sampled males with stable smoking habits. | 1993 | Clin Physiol | pmid:8519161 |
| Jendryczko A and Tomala J | An imbalance between the excretion of thromboxane and prostacyclin metabolites in women after the menopause. | 1993 | Zentralbl Gynakol | pmid:8503234 |
| O'Brien WF et al. | The effect of acetaminophen on prostacyclin production in pregnant women. | 1993 | Am. J. Obstet. Gynecol. | pmid:8475962 |
| Morio H et al. | Effect of the infusion of OKY-046, a thromboxane A2 synthase inhibitor, on urinary metabolites of prostacyclin and thromboxane A2 in healthy human subjects. | 1993 | Thromb. Haemost. | pmid:8470052 |